Heron Therapeutics, Inc. /De/

Ownership Transactions Reported by 17 Insiders

	Insiders	Shares	%	Avg Price	Total $
Buys	4	+3.96 M	100%	$1.34	+$5.29 M
Sells	0
Net	+4	+3.96 M	100%		+$5.29 M

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Rubric Capital Management LP	10%+ Owner	$57.4 M			Jul 21, 2023
Adam Morgan	Director	$16.7 M	+$5 M	+42.6%	Jan 19, 2024
Velan Capital Investment Management LP	Other*	$9.68 M			Jan 30, 2023
Kevin Kotler	Director	$1.24 M			Feb 22, 2023
Craig A. Collard	Chief Executive Officer, Director	$968 K	+$138 K	+16.6%	Apr 19, 2024
Barry D. Quart	Chief Executive Officer, Director	$630 K			Jan 18, 2023
Ira Duarte	EVP, Chief Financial Officer	$364 K	+$75.6 K	+26.2%	Jun 16, 2024
William P. Forbes	EVP, Chief Development Officer	$351 K	+$74.2 K	+26.8%	Jun 6, 2024
John Poyhonen	President & CCO	$160 K			Apr 13, 2023
Susan Rodriguez	Director	$149 K			Jan 19, 2024
Sharmila Dissanaike	Director	$149 K			Jan 19, 2024
Waage Christian	Director	$142 K			Jan 19, 2024
Craig A. Johnson	Director	$142 K			Jan 19, 2024
Lisa Peraza	VP, Chief Accounting Officer	$135 K			Jan 19, 2024
David Leslie Szekeres	EVP, Chief Operating Officer	$123 K			Jul 13, 2023
Kimberly Manhard	EVP, Drug Development	$121 K			Apr 13, 2023
Stephen Davis	Director	$112 K			Dec 16, 2022

Insider	Class	Transaction	%	Value $	Price $	Shares	Shares Owned	Date	Ownership